Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy
出版年份 2017 全文链接
标题
Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy
作者
关键词
-
出版物
Scientific Reports
Volume 7, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-04-21
DOI
10.1038/s41598-017-01279-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation
- (2016) A D Garg et al. CELL DEATH AND DIFFERENTIATION
- Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration
- (2016) Matthias Van Woensel et al. JOURNAL OF CONTROLLED RELEASE
- Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma
- (2016) Abhishek D. Garg et al. Science Translational Medicine
- Prioritization schema for immunotherapy clinical trials in glioblastoma
- (2016) Tiffany R. Hodges et al. OncoImmunology
- CCR 20th Anniversary Commentary: Bevacizumab in the Treatment of Glioblastoma--The Progress and the Limitations
- (2015) N. Mar et al. CLINICAL CANCER RESEARCH
- Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?
- (2015) A. D. Cox et al. CLINICAL CANCER RESEARCH
- Limited advances in therapy of glioblastoma trigger re-consideration of research policy
- (2015) Guido Frosina CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: In vivo evaluation
- (2015) Fabienne Danhier et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- Can oxytocin treat autism?
- (2015) L. J. Young et al. SCIENCE
- Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal
- (2015) Abhishek D. Garg et al. Oncotarget
- Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale meta-analysis
- (2015) Abhishek D. Garg et al. OncoImmunology
- Brain Tumor Immunotherapy: What have We Learned so Far?
- (2015) Stefaan Willy Van Gool Frontiers in Oncology
- Classification of current anticancer immunotherapies
- (2015) Lorenzo Galluzzi et al. Oncotarget
- Combining Bevacizumab with Temozolomide Increases the Antitumor Efficacy of Temozolomide in a Human Glioblastoma Orthotopic Xenograft Model
- (2015) Véronique Mathieu et al. NEOPLASIA
- Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors
- (2014) Diego O. Croci et al. CELL
- Galectin-1 and Immune Suppression during Radiotherapy
- (2014) J. W. Welsh et al. CLINICAL CANCER RESEARCH
- Clinical Efficacy of Tumor Antigen-Pulsed DC Treatment for High-Grade Glioma Patients: Evidence from a Meta-Analysis
- (2014) Jun-Xia Cao et al. PLoS One
- T-Cell and NK-Cell Infiltration into Solid Tumors: A Key Limiting Factor for Efficacious Cancer Immunotherapy
- (2014) I. Melero et al. Cancer Discovery
- Linking tumor hypoxia with VEGFR2 signaling and compensatory angiogenesis
- (2014) Diego O Croci et al. OncoImmunology
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
- (2013) Gabriela Bindea et al. IMMUNITY
- Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity
- (2013) Tina Verschuere et al. INTERNATIONAL JOURNAL OF CANCER
- Altered galectin-1 serum levels in patients diagnosed with high-grade glioma
- (2013) Tina Verschuere et al. JOURNAL OF NEURO-ONCOLOGY
- Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients
- (2013) Laura Ridolfi et al. Journal of Translational Medicine
- Thwarting galectin-induced immunosuppression in breast cancer
- (2013) Mariana Salatino et al. OncoImmunology
- Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?
- (2013) Matthias van Woensel et al. Cancers
- Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination
- (2012) Steven De Vleeschouwer et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Macrophage plasticity and polarization: in vivo veritas
- (2012) Antonio Sica et al. JOURNAL OF CLINICAL INVESTIGATION
- Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion
- (2012) L Toussaint et al. Molecular Cancer
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment
- (2011) Suzanne Craft ARCHIVES OF NEUROLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity
- (2010) V. L. Thijssen et al. CANCER RESEARCH
- Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma
- (2010) Clovis O. da Fonseca et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Knocking Down Galectin 1 in Human Hs683 Glioblastoma Cells Impairs Both Angiogenesis and Endoplasmic Reticulum Stress Responses
- (2009) Marie Le Mercier et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma
- (2009) Wim Maes et al. NEURO-ONCOLOGY
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- Evidence of galectin-1 involvement in glioma chemoresistance☆
- (2008) Marie Le Mercier et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now